$HCWB
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
Healthcare
Sector
Biotechnology
Industry
Hing C. Wong
CEO
36
Employees
$3.20
Current Price
$2.09M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 3 | 3 | $99,992.97 | 38,682 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 3 | 3 | $99,992.97 | 38,682 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 3 | 3 | $99,992.97 | 38,682 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 3 | 3 | $99,992.97 | 38,682 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 4 | 6 | $529,993.22 | 344,732 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Wong Hing C Director | Purchase | 23,210 | $2.58 | $59,997.85 | View Details |
| Jul 29, 2026 | Flowers Lee SVP of Business Development | Purchase | 7,736 | $2.58 | $19,997.56 | View Details |
| Jul 29, 2026 | GARRETT SCOTT T Director | Purchase | 7,736 | $2.58 | $19,997.56 | View Details |
| May 22, 2026 | Wong Hing C Director | Purchase | 113,879 | $1.41 | $159,999.99 | View Details |
| May 22, 2026 | GARRETT SCOTT T Director | Purchase | 177,936 | $1.41 | $250,000.08 | View Details |
| May 22, 2026 | Byam Rebecca Chief Financial Officer | Purchase | 14,235 | $1.41 | $20,000.17 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.